DE SANCTIS, Rita
 Distribuzione geografica
Continente #
NA - Nord America 2.113
EU - Europa 572
AS - Asia 282
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 5
SA - Sud America 5
Totale 3.057
Nazione #
US - Stati Uniti d'America 2.074
SG - Singapore 145
FI - Finlandia 138
IE - Irlanda 112
IT - Italia 92
CN - Cina 78
NG - Nigeria 66
DE - Germania 57
FR - Francia 52
CA - Canada 39
TR - Turchia 31
SE - Svezia 29
NL - Olanda 25
GB - Regno Unito 22
BE - Belgio 14
IL - Israele 11
EU - Europa 10
IN - India 10
CZ - Repubblica Ceca 6
RU - Federazione Russa 6
AU - Australia 5
ES - Italia 4
IR - Iran 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
GR - Grecia 3
RO - Romania 3
BR - Brasile 2
MK - Macedonia 2
PL - Polonia 2
SI - Slovenia 2
AT - Austria 1
EE - Estonia 1
HK - Hong Kong 1
IQ - Iraq 1
MD - Moldavia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 3.057
Città #
Wilmington 467
Chandler 232
San Mateo 172
Ann Arbor 166
Helsinki 138
Dublin 112
Leawood 100
Singapore 91
Boardman 89
New York 87
Lawrence 85
Princeton 85
Shanghai 73
Benin City 66
Fairfield 56
Ashburn 53
Paris 50
Woodbridge 44
Toronto 38
Kocaeli 31
Amsterdam 24
London 16
Brussels 14
Milan 14
Seattle 14
Monmouth Junction 12
Phoenix 12
Los Angeles 8
Brno 6
Munich 6
Norwalk 6
San Diego 6
Abbiategrasso 5
Pune 5
Santa Clara 5
Bergamo 4
Ardabil 3
Buenos Aires 3
Chandigarh 3
Cisterna Di Latina 3
Falkenstein 3
Genova 3
Moscow 3
Nuremberg 3
Redwood City 3
Sacramento 3
Agrate Brianza 2
Arganda 2
Augusta 2
Austin 2
Beijing 2
Berlin 2
Bitola 2
Bradford 2
Clearwater 2
Des Moines 2
Henderson 2
Houston 2
Kemerovo 2
Las Vegas 2
Ljubljana 2
Melbourne 2
Redmond 2
Röllbach 2
São Paulo 2
A Coruña 1
Andover 1
Arlington 1
Athens 1
Basra 1
Bialystok 1
Buffalo 1
Champaign 1
Chicago 1
Chisinau 1
Collegeville 1
Frankfurt am Main 1
Groningen 1
Guelph 1
Gunzenhausen 1
Hangzhou 1
Hillsboro 1
La Canada Flintridge 1
Mainz 1
Milwaukee 1
Pittsburgh 1
Pretoria 1
Raleigh 1
Saint Paul 1
Sydney 1
Taipei 1
Tallinn 1
Tappahannock 1
Tel Aviv 1
Valladolid 1
Vancouver 1
Vienna 1
Washington 1
Zanjan 1
Totale 2.494
Nome #
Survival Outcome and Prognostic Factors After Pulmonary Metastasectomy in Sarcoma Patients A 18-Year Experience at a Single High-volume Referral Center 73
Biological characteristics and long-term outcomes in node-negative breast cancer 65
Response to Sunitinib in an Adult Patient With Rhabdoid Renal Cell Carcinoma 55
Colorectal cancer liver metastases treated with target therapies: monitoring response with constrat-enhanced ultrasonography (CE-US). 54
Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma. 54
Atypical Lipomatous Tumors: Should They be Treated Like Other Sarcoma or Not? Surgical Consideration from a Bi-Institutional Experience 50
Carcinoma gastrico metastatico e Docetaxel, Cisplatino, Fluorouracile (DCF) settimanale: tolleranza e risposta 50
Zoledronic acid (ZA) and treatment of bone metastasis in patients with advanced lung cancer (NSCLC and SCLC). 49
Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors 49
Early response evaluation of antiangiogenic therapy: use of contrast-enhanced ultrasonography (CE-US) in hepatocellular carcinoma 46
Colorectal cancer liver metastases treated with target therapies: monitoring response with contrast-enhanced ultrasonography (CE-US). 45
Docetaxel in combination with gemcitabine as second line treatment in patients with platinum resistant advanced NSCLC 44
Descripcion de un sistema de realidad virtual dirigido a la promocion de bienestar emocional en pazientes oncologicoa hospidalizados: ensayo fase II OncoHelp 44
Capecitabine in elderly patients with metastatic breast cancer 44
Prognostic factors and outcome of HER2+ breast cancer with CNS metastases 43
Long-term Follow-up and Post-relapse Outcome of Patients with Localized Retroperitoneal Sarcoma Treated in the Italian Sarcoma Group-Soft Tissue Sarcoma (ISG-STS) Protocol 0303 43
wALT trial (Phase I-II): weekly non-pegylated liposomal anthracycline and taxane combination in first line breast cancer chemotherapy 43
HER2-positive breast cancer and CNS metastases: Prognostic factors and clinical outcome 42
Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapy 42
First-line chemotherapy in over-70 patients with colon cancer. 42
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy 42
Unsupervised versus Supervised Identification of Prognostic Factors in Patients with Localized Retroperitoneal Sarcoma: A Data Clustering and Mahalanobis Distance Approach 41
WALT TRIAL (PHASE III): WEEKLY NON PEGYLATED LIPOSOMAL ANTHRACYCLINE AND TAXANE COMBINATION IN FIRSTLINE BREAST CANCER CHEMOTHERAPY 41
Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma 41
Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab 41
Dietary chemoprevention of colorectal cancer 40
Efficacy and tolerability of a single-day three drugs combination of aprepitant, palonosetron and dexamethasone in patients receiving moderately emetogenic chemotherapy 40
Feasibility of preoperative chemotherapy with or without radiation therapy in localized soft tissue sarcomas of limbs and superficial trunk in the Italian sarcoma group/grupo español de investigación en sarcomas randomized clinical trial: Three versus five cycles of full-dose epirubicin plus ifosfamide 40
Predictive Factors of Eribulin Activity in Metastatic Breast Cancer Patients 39
Platinum salts in the treatment of BRCA-associated breast cancer: A true targeted chemotherapy? 39
Activity of regorafenib in advanced pretreated soft tissue sarcoma: Results of a single-center phase II study 39
A Study of Clinical Features and Risk Factors of Self-Referring Emergency Department Headache Patients: A Comparison with Headache Center Outpatients 38
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial 38
Never too old to fight breast cancer 37
Bevacizumab in combination with FOLFIRI as first-line treatment for metastatic colorectal cancer: outcomes from a single center experience 36
Capecitabine in elderly breast cancer patients 36
Efficacy of trabectedin in advanced soft tissue sarcoma: Beyond lipo- and leiomyosarcoma 36
TNBC universe: A monocentric retrospective analyses of TILs and AR as prognostic markers 35
Pulmonary sarcomatoid carcinoma presenting both ALK rearrangement and PD-L1 high positivity: a case report on the therapeutic regimen 35
A monocentric retrospective analysis of TILs and AR as hints for prognosis definition in TNBC 35
Phase I, pharmacokinetics, pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors 34
Safety and efficacy of bevacizumab with first-line FOLFIRI for metastatic colorectal cancer: single center experience 34
Primary ovarian insufficiency associated with pazopanib therapy in a breast angiosarcoma patient A CARE-compliant case report 33
Trabectedin for the treatment of soft tissues sarcomas 32
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group 32
Imatinib mesylate in desmoplastic small round cell tumors 31
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial 31
Phase I, pharmacokinetic (PK), pharmacodynamic (PD) study of lapatinib (L) in combination with sorafenib (S) in patients with advanced refractory solid tumors 31
Palonosetron plus three-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 29
Phase I, Pharmacokinetics (PK), Pharmacodynamic (PD) Study of Lapatinib (L) in Combination With Sorafenib (S) in Patients With Advanced Refractory Solid Tumours 29
Perfusion Computed Tomography as prognostic and predictive factor in patients with colorectal cancer liver metastases treated with bevacizumab 28
Role of Surgery in the Multimodal Treatment of Primary and Recurrent Leiomyosarcoma of the Inferior Vena Cava 28
A pilot analysis of headache disorders in breast cancer patients 28
SAFETY AND EFFICACY OF SORAFENIB FOR ADVANCED HEPATOCELLULAR CARCINOMA 27
Palonosetron plus three-day aprepitant and dexamethasone schedule to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 27
Imatinib mesylate in desmoplastic small round cell tumour 27
SAFETY AND EFFICACY OF ORAL COMBINATION CHEMOTHERAPY IN METASTATIC BREAST CANCER: VINORELBINE AND CAPECITABINE 26
PERFUSION COMPUTED TOMOGRAPHY AS PROGNOSTIC AND PREDICTIVE FACTOR IN PATIENTS WITH COLORECTAL CANCER LIVER METASTASES TREATED WITH BEVACIZUMAB 26
The role of docetaxel in the multimodal treatment of non-small cell lung cancer 26
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9) 26
Juxtaglomerular cell tumor: Multicentric synchronous disease associated with paraneoplastic syndrome 25
Safety, tolerability and early response evaluation of sarafenib in hepatocellular carcinoma in erderly: use of contrast-enhanced ultrasonography (CE-US). 25
Treatment of malignant pleural mesothelioma: current status and future directions 25
Insights for the application of TILs and AR in the treatment of TNBC in routine clinical practice 25
Neutrophil to Lymphocyte Ratio (NLR) as predictive factor in patients with metastatic soft tissue sarcoma (STS) treated with trabectedin (T). 24
Oral vinorelbine in elderly or unfit patients with metastatic NSCLC 24
Phase II study: Docetaxel-cisplatin and pro drug tegafur (TPF) as neoadjuvant treatment in advanced patients with head and neck cancer (HNC): Results and correlation between tandem magnesium/creatinine and toxicity 24
Safety, Tollerability and Early Response Evaluation of Sorafenib In Hepatocellular Carcinoma In Elderly: Use of Contrast-enhanced Ultrasonography (ce-us) 23
Trabectedin for the treatment of soft tissue sarcoma 23
From seaside to bedside: Current evidence and future perspectives in the treatment of breast cancer using marine compounds 22
The therapeutic potential of duloxetine in prostate cancer-related fatigue 22
Primary breast leiomyosarcoma and synchronous homolateral lung cancer: a case report 22
Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 22
Sporadic desmoid tumors of the abdominal wall: the results of surgery 22
Safety and efficacy of oral combination of vinorelbine and capecitabine in metastatic breast cancer 22
Safety and efficacy of oral vinorelbine and capecitabine combination for metastatic breast cancer 22
Temporal–occipital glioblastoma presenting with Alice in Wonderland Syndrome in a patient with a long-time history of migraine without aura 22
Superiority of CHOI vs RECIST criteria in evaluating outcome of advanced soft tissue sarcoma (STS) patients treated with sorafenib 21
Non-pegylated liposomal doxorubicin plus ifosfamide in metastatic soft tissue sarcoma: results from a phase-II trial 21
Never too old to fight breast cancer: A case report 21
Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: A phase I-II study from the Italian Sarcoma Group 21
A systematic review of systematic reviews and pooled meta-analysis on pharmacological interventions to improve cancer-related fatigue 21
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy 20
Volumetric-modulated-arc-therapy versus 3D-conformal-radiotherapy for sarcoma of extremities 18
Real-life data on the cardiac toxicity of adjuvant fixed-dose subcutaneous trastuzumab in HER2-positive breast cancer 18
Defining T cell dysfunctionality in breast cancer by single cell analysis: Implications for immunotherapy 17
Neoadjuvant chemotherapy in hormone receptor-positive/HER2-negative early breast cancer: when, why and what? 17
Clinical Review on the Management of Breast Cancer Visceral Crisis 16
A Propensity Score Matching Study on the Effect of OnabotulinumtoxinA Alone versus Short-Term Psychodynamic Psychotherapy Plus Drug-of-Choice as Preventive Therapy in Chronic Migraine: Effects and Predictive Factors 15
[Integrated treatment of breast cancer: review of our experience] 14
The Role of Female Reproductive Hormones in the Association between Migraine and Breast Cancer: An Unanswered Question 14
[The clinical significance of lymph node micrometastases and of concept of sentinel lymph node] 14
Re: Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients: Sympathetic nervous system activity on breast cancer: the story of migraine 14
Imaging Correlates between Headache and Breast Cancer: An [18F]FDG PET Study 14
Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targets 13
Controversies and Opportunities in the Clinical Daily Use of the 21-Gene Assay for Prognostication and Prediction of Chemotherapy Benefit in HR+/HER2- Early Breast Cancer 13
The Relationship among Bowel [18]F-FDG PET Uptake, Pathological Complete Response, and Eating Habits in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy 13
Opportunities and Challenges of Synthetic Data Generation in Oncology 12
Profiling the Spectrum of Headache Disorders on 440 Breast Cancer Patients: Highlights on Clinical and Pathological Mechanisms 10
Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer 10
Totale 3.092
Categoria #
all - tutte 27.366
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.366


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202058 0 0 0 0 0 0 0 0 0 0 0 58
2020/2021973 5 2 7 2 8 287 158 50 245 108 4 97
2021/2022445 32 2 15 79 14 7 12 64 44 77 89 10
2022/2023898 182 19 114 58 79 46 4 72 137 97 78 12
2023/2024779 54 63 164 34 30 110 52 32 8 21 67 144
2024/202528 27 1 0 0 0 0 0 0 0 0 0 0
Totale 3.181